A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus
Clinical trial NCT00962832 · COMPLETED
Trial details
- NCT number
- NCT00962832
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-01-01
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.